Cosmos Health Inc. (NASDAQ:COSM) Sees Large Drop in Short Interest

Cosmos Health Inc. (NASDAQ:COSM) saw a significant drop in short interest in January. As of January 31st, there was short interest totalling 531,900 shares, a drop of 39.7% from the January 15th total of 881,600 shares. Based on an average daily trading volume, of 458,400 shares, the days-to-cover ratio is presently 1.2 days. Approximately 2.9% of the shares of the stock are short sold.

Cosmos Health Trading Down 3.2 %

COSM stock opened at $0.62 on Friday. The company has a quick ratio of 1.24, a current ratio of 1.44 and a debt-to-equity ratio of 0.08. Cosmos Health has a twelve month low of $0.47 and a twelve month high of $1.58. The company has a market cap of $14.40 million, a P/E ratio of -0.25 and a beta of 5.56. The business has a fifty day moving average of $0.71 and a 200-day moving average of $0.84.

Insider Activity

In related news, CEO Grigorios Siokas purchased 257,334 shares of the firm’s stock in a transaction dated Friday, December 20th. The shares were acquired at an average cost of $0.58 per share, with a total value of $149,253.72. Following the completion of the purchase, the chief executive officer now directly owns 3,774,314 shares of the company’s stock, valued at $2,189,102.12. This trade represents a 7.32 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Georgios Terzis acquired 85,778 shares of the company’s stock in a transaction that occurred on Friday, December 20th. The stock was bought at an average price of $0.58 per share, with a total value of $49,751.24. Following the transaction, the chief financial officer now directly owns 727,263 shares in the company, valued at $421,812.54. The trade was a 13.37 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 688,750 shares of company stock worth $437,803. 15.61% of the stock is owned by corporate insiders.

Institutional Trading of Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Geode Capital Management LLC lifted its holdings in shares of Cosmos Health Inc. (NASDAQ:COSM) by 29.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 193,432 shares of the company’s stock after buying an additional 43,704 shares during the quarter. Geode Capital Management LLC owned about 0.83% of Cosmos Health worth $129,000 at the end of the most recent quarter. Institutional investors and hedge funds own 12.61% of the company’s stock.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.